Acadia Healthcare Company (ACHC) - P/E Multiple

Corporate emblem and logo of Acadia Healthcare Company (ACHC)

The target P/E of Acadia Healthcare (ACHC) reflects the business valuation trend, where -3.10 determines this specific parameter level. Acadia Healthcare (ACHC) dominance in the US psychiatric segment neutralizes price wars due to a shortage of beds. Revenue stability is ensured by broad market coverage across Britain and America. An uninterrupted flow of medications to clinics guarantees patient safety and continuity of therapy.

P/E Multiple: Acadia Healthcare (ACHC) for 07/04/2022 - 11/10/2026

Comprehensive metric breakdowns and analytics for Acadia Healthcare Inc (ACHC)

Summary company analysis:ACHC, acadiahealthcare.com
Product sample of Acadia Healthcare

Stable demand for psychiatric care in the US offsets the risks of Acadia Healthcare (ACHC) narrow specialization, creating a predictable cash flow. By analyzing P/E valuation dynamics, an investor determines the payback period of shares via net income: low values minimize overpayment for the asset, while multiplier stagnation may signal low capital efficiency within this investment class.